A	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
massive	massive	O	O	O	O
rhabdomyolysis	rhabdomyolysis	O	DISEASE	OTHERS	I
following	following	O	O	O	O
molindone	molindone	O	O	OTHERS	I
administration	administration	O	O	O	O
.	.	O	O	O	O

Rhabdomyolysis	rhabdomyolysis	O	DISEASE	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
potentially	potentially	O	O	O	O
lethal	lethal	O	O	O	O
syndrome	syndrome	O	O	O	O
that	that	O	O	O	O
psychiatric	psychiatric	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
seem	seem	O	O	O	O
predisposed	predisposed	O	O	O	O
to	to	O	O	O	O
develop	develop	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
clinical	clinical	O	O	O	O
signs	signs	O	DISEASE	OTHERS	I
and	and	O	DISEASE	OTHERS	I
symptoms	symptoms	O	DISEASE	OTHERS	I
,	,	O	O	O	O
typical	typical	O	O	O	O
laboratory	laboratory	O	O	O	O
features	features	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
complications	complications	O	O	O	O
of	of	O	O	O	O
rhabdomyolysis	rhabdomyolysis	O	DISEASE	OTHERS	I
are	are	O	O	O	O
presented	presented	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
schizophrenic	schizophrenic	O	DISEASE	OTHERS	I
patient	patient	O	O	O	O
is	is	O	O	O	O
reported	reported	O	O	O	O
to	to	O	O	O	O
illustrate	illustrate	O	O	O	O
massive	massive	O	O	O	O
rhabdomyolysis	rhabdomyolysis	O	DISEASE	OTHERS	I
and	and	O	O	O	O
subsequent	subsequent	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
following	following	O	O	O	O
molindone	molindone	O	O	OTHERS	I
administration	administration	O	O	O	O
.	.	O	O	O	O

Physicians	physicians	O	O	O	O
who	who	O	O	O	O
prescribe	prescribe	O	O	O	O
molindone	molindone	O	O	OTHERS	I
should	should	O	O	O	O
be	be	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
reaction	reaction	O	O	O	O
.	.	O	O	O	O

